SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-398784
Filing Date
2013-10-15
Accepted
2013-10-15 06:07:33
Documents
3
Period of Report
2013-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d611997d8k.htm 8-K 27303
2 EX-2.1 d611997dex21.htm EX-2.1 240839
3 EX-99.1 d611997dex991.htm EX-99.1 12185
  Complete submission text file 0001193125-13-398784.txt   281854
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

IRS No.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15313 | Film No.: 131149052
SIC: 2833 Medicinal Chemicals & Botanical Products